Pembrolizumab
#
Find similar titles
- (rev. 3)
- Hyungyong Kim
Structured data
Pembrolizumab (formerly MK-3475 and Lambrolizumab, trade name Keytruda, 키트루다) is a humanized antibody used in Cancer immunotherapy. It blocks a protective mechanism on cancer cells, and allows the Immune system to destroy those cancer cells. It targets PD-1 receptor. (https://en.wikipedia.org/wiki/Pembrolizumab)
관련정보
- Keytruda – 범용 항암치료제의 등장인가
- 미 FDA, 조직과 무관한(tissue-independent) 항암제 신속승인 : 키트루다의 약물 사용 범위 확대
Incoming Links #
Related Articles (Article 0) #
Suggested Pages #
- 0.201 Cytokine release syndrome
- 0.072 pVAC-Seq
- 0.056 CloudNeo
- 0.025 T cell
- 0.025 Durvalumab
- 0.025 Hyuna Kim
- 0.025 PD-L1
- 0.025 여보이
- 0.025 Major histocompatibility complex
- 0.025 Nature Reviews Genetics
- More suggestions...